Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Sodium valproate 300mg modified-release tablets |
BNF code | 0408010W0AAA1A1 |
Virtual Therapeutic Moiety | Sodium valproate |
Date identifier became valid | 21 Oct 2020 |
Previous product identifier | 322966005 |
Basis of preferred name | INNM - International Non-proprietary Name (Modified) |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Sodium valproate |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 300.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletmodified-release.oral |
Dose Form | |
Formulation | Modified-release tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) | |
Epilim Chrono 300 tablets (CST Pharma Ltd) | |
Epilim Chrono 300 tablets (Sanofi) | |
Epilim Chrono 300 tablets (Sigma Pharmaceuticals Plc) | |
Epival CR 300mg tablets (G.L. Pharma UK Ltd) | |
Virtual Medicinal Product Packs | |
Sodium valproate 300mg modified-release tablets 100 tablet | |
Sodium valproate 300mg modified-release tablets 30 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.